Stay updated on IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial
Sign up to get notified when there's something new on the IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial page.

Latest updates to the IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial page
- Check4 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the study record with an error screen. As a result, the essential trial information is no longer visible.SummaryDifference16%

- Check11 days agoChange DetectedThe page now shows Revision: v3.7.0, replacing the previous v3.6.6. This indicates a new version of the page metadata rather than a change to the study details.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe page's revision indicator now reads v3.6.6, replacing v3.6.5, which represents a small internal update to the page template or content without changing the study details.SummaryDifference0.1%

- Check53 days agoChange DetectedThe revision tag on the page was updated from v3.6.4 to v3.6.5, indicating a new version of the page or its underlying template was deployed.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page's revision tag has been updated from v3.6.3 to v3.6.4, representing a new build deployment. It does not indicate any visible content or user-facing functionality changes based on the provided data.SummaryDifference0.1%

- Check88 days agoChange DetectedThe revision label on the page updated from v3.6.2 to v3.6.3, reflecting an internal update without changing the displayed study details.SummaryDifference0.1%

Stay in the know with updates to IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial page.